Paul Bollyky
@pbollyky.bsky.social
210 followers 160 following 13 posts

Stanford University Infectious Disease Doc studying bacteriophages, bacterial infections, and innate immunity.

Biology 56%
Medicine 19%
Posts Media Videos Starter Packs

pbollyky.bsky.social
Check it out - phages seem to cross the placenta from mom to fetus! Check it out here: insight.jci.org/articles/vie...
Congrats to Jen Sequioia, Naomi Haddock and our terrific collaborators in the Winn Lab

pbollyky.bsky.social
Very excited to see this preprint from @JasonAndrewsMD on a method using phages to detect environmental pathogens - this is a terrific idea
www.medrxiv.org/content/10.1...

pbollyky.bsky.social
We find JukA (formerly YaaW, WP_003137196.1) in 10 of our 80 CPA. With OMK01, The 10 Juk+ strains are resistant but so are 66 Juk- strains. The 4 susceptible strains are indeed Juk-. The association with Juk was non-significant.

pbollyky.bsky.social
I'm thrilled to welcome our new class of Infectious Disease fellows to Stanford! We are so excited have such a talented group of physicians coming to join us next year.

pbollyky.bsky.social
Thanks for these great questions Chase and for your interest in our work!

pbollyky.bsky.social
I would wonder what MOI was used in other studies with phikz and PA14. We used 100.

pbollyky.bsky.social
Many thanks to our outstanding collaborators including Liz Burgener, Carlos Milla, and Niaz Banaei

pbollyky.bsky.social
In this work, we describe a streamlined protocol for identifying cross-resistant phages and antibiotics, which we call complementarity grouping. Cocktails targeting 3 or more complementarity groups were effective vs >80% of P. aeruginosa isolates. Add a synergistic antibiotic and its >96%